DOCS
NEUTRALDr. Martens Announces Director/PDMR Shareholding
The retailer has announced a transaction by a director involving the vesting and sale of restricted stock units.
Dr. Martens
55.75GBX
0.72%
Market Cap
537.79M
Volume
892.22k
65% of avg
P/E Ratio
0.10
EPS (TTM)
5.55
Beta
0.11
Day Range
55.10p - 57.90p
52 Week Range
43.02p55.75p93.25p
55.75p
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer has announced that its directors and PDMRs have acquired additional shares in the company through an employee share scheme.
DOCS
NEUTRALDr. Martens Announces Director/PDMR Shareholding Changes
The retailer has announced changes to the shareholdings of its directors and other persons discharging managerial responsibilities.
DOCS
NEUTRALDr. Martens Announces Director Share Purchase
The retailer has announced a director has purchased shares in the company.
DOCS
NEUTRALDr. Martens Announces Director/PDMR Shareholding Changes
The retailer announces changes to director and PDMR shareholdings through its employee share scheme.
DOCS
NEUTRALDr. Martens directors purchase shares under SIP
The retailer has announced that directors have purchased shares under the company's employee share scheme.
DOCS
NEUTRALDr. Martens Appoints New Non-Executive Directors
The retailer has appointed two new Non-Executive Directors to its Board, strengthening its leadership team with experienced industry professionals.
DOCS
NEUTRALDr. Martens Q3 Trading Meets Expectations, USA Performance Improves
The iconic footwear brand reports mixed Q3 results, with growth in Americas and APAC markets offset by challenges in EMEA. Overall constant currency revenue increased, while reported figures declined due to currency impacts.
DOCS
NEUTRALDr. Martens Directors Acquire Shares Under SIP
Footwear brand Dr. Martens announces directors have acquired a modest number of shares under the company's employee share scheme.
DOCS
GOODArtemis Boosts Stake in Dr. Martens to Over 9%
Footwear brand Dr. Martens sees increased institutional backing